Cardio-Oncology Registry
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: No interventions are planned.
- Who it may be relevant to
- Registry conditions: Cancer, Cardiac Disease, Metabolic Syndrome, Arrhythmia. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Cardio-Oncologie: étude Pilote évaluant la faisabilité, Utilité Concrète, Interdisciplinaire d'Une Unité Spécialisée
Overview
Cardio-oncology is an emerging field. Most of the data available have been issued from either retrospective analysis, industry data or pharmacovigilance data. These data sources include a number of bias. CONFUCIUS is a single tertiary centre prospective registry including all patients who have been referred for cardio-oncology assessemnt. The objectives are to provide a comprehensive vue of cardoi-oncology, enable to detect early signals of cardiotoxicity and enhance ancillary projetcts aiming at specific populations (e.g., type of cancer) and/or drugs.
Interventions
- Other No interventions are planned
Non applicable
Primary outcome measures
- Incidence of cardio-toxicty [Time frame: 5 years]
Secondary outcome measures (10)
- Analysis of cardiotoxicity [Time frame: 5 years]
- Analysis of cardioprotective strategies [Time frame: 5 years]
- Analysis of underlying cardiovacsular profile [Time frame: 5 years]
- Analysis of arrhythmias [Time frame: 5 years]
- Precision medicine [Time frame: 5 years]
- Oncology [Time frame: 5 years]
- Cardiovascular outcomes [Time frame: 10 years]
- Any advserse event [Time frame: 5 years]
- Behaviour [Time frame: 5 years]
- Metabolic [Time frame: 5 years]
Eligibility criteria
Inclusion criteria
- referred to cardio-oncology
Exclusion criteria
- refusal to participate
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
France · 1 center
- Assistance Publique Hôpitaux de Paris - Centre Université de Paris — Paris
Identifiers
NCT: NCT04407780 · 00011928